# Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects

> **NCT07457008** · PHASE1 · COMPLETED · sponsor: **West China Second University Hospital** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** The 10mg dose group
- **DRUG:** The 20mg dose group
- **DRUG:** The 30mg dose group
- **OTHER:** The Placebo group

## Key facts

- **NCT ID:** NCT07457008
- **Lead sponsor:** West China Second University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2021-09-03
- **Final completion:** 2021-09-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457008, "Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07457008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*